Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Benzylcetyldimethylammonium
2. Benzylcetyldimethylammonium Chloride Hydrate
3. Bzk-c16
1. 10328-34-4
2. Cetyldimethylbenzylammonium
3. Cetalkonium Ion
4. Cetalkonium Cation
5. Benzyl-hexadecyl-dimethylazanium
6. Benzyldimethylhexadecylammonium
7. Benzylhexadecyldimethylammonium
8. Benzenemethanaminium, N-hexadecyl-n,n-dimethyl-
9. Fhg725432z
10. Benzylcetyldimethylammonium
11. Unii-fhg725432z
12. Benzyldimethylhexadecyl Ammonium
13. Cbnbr
14. Benzyl Hexadecyl Dimethyl Ammonium
15. Benzyl-hexadecyl-dimethyl-ammonium
16. Benzyldimethylhexadecylammonium Cation
17. Benzylcetyldimethylaminium
18. Schembl233796
19. Chembl1624075
20. Dtxsid3047007
21. Benzalkonium Chloride C16
22. Chebi:135523
23. Zinc14233334
24. Db11583
25. A901252
26. Sr-01000944408
27. Sr-01000944408-1
28. Q27277991
29. Benzenemethanaminium, N-hexadecyl, N,n-dimethyl-
30. 51895-89-7
Molecular Weight | 360.6 g/mol |
---|---|
Molecular Formula | C25H46N+ |
XLogP3 | 9.5 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 0 |
Rotatable Bond Count | 17 |
Exact Mass | 360.363025472 g/mol |
Monoisotopic Mass | 360.363025472 g/mol |
Topological Polar Surface Area | 0 Ų |
Heavy Atom Count | 26 |
Formal Charge | 1 |
Complexity | 291 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Cetalkonium is used as a surfactant, germicide, fungicide, mildew preventive agents in silicone-based water repellents, emulsifier, disinfectant, topical anti-infective, and antiseptic antimicrobial for pharmaceuticals. For its chemical properties and its antiseptical characteristics, cetalkonium can be used in a wide variety of products as part of the formulations and it is also determined to be an active antiseptic ingredient in over-the-counter preparations.
Cetalkonium is an antimicrobial agent and it has shown to be effective against both gram-positive, gram-negative bacteria and fungi. From this property, it has been shown to present a better activity against the gram-negative organisms.
Absorption
Cetalkonium is used mainly topically and it is not absorbed. When administered orally and parenterally, cetalkonium absorption may happen but it is very insignificant.
Route of Elimination
As cetalkonium is not absorbed, this pharmacokinetic property is not relevant. When administered orally, most of the administered dose is excreted unchanged in the feces as it is very poorly absorbed.
Volume of Distribution
As cetalkonium is not absorbed, this pharmacokinetic property is not relevant.
Clearance
As cetalkonium is not absorbed, this pharmacokinetic property is not relevant.
As cetalkonium is not absorbed, this pharmacokinetic property is not relevant.
As cetalkonium is not absorbed, this pharmacokinetic property is not relevant.
The activity of cetalkonium is based on the creation of a positive charge which permits a bio-adhesive property to negative surfaces. This property allows cetalkonium to disrupt the cell membrane, inactivate enzymes and denature proteins. This type of mechanism allows this type of agents to present a broad spectrum.
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
A Cetalkonium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cetalkonium, including repackagers and relabelers. The FDA regulates Cetalkonium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cetalkonium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cetalkonium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cetalkonium supplier is an individual or a company that provides Cetalkonium active pharmaceutical ingredient (API) or Cetalkonium finished formulations upon request. The Cetalkonium suppliers may include Cetalkonium API manufacturers, exporters, distributors and traders.
click here to find a list of Cetalkonium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cetalkonium DMF (Drug Master File) is a document detailing the whole manufacturing process of Cetalkonium active pharmaceutical ingredient (API) in detail. Different forms of Cetalkonium DMFs exist exist since differing nations have different regulations, such as Cetalkonium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cetalkonium DMF submitted to regulatory agencies in the US is known as a USDMF. Cetalkonium USDMF includes data on Cetalkonium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cetalkonium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cetalkonium suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Cetalkonium Drug Master File in Japan (Cetalkonium JDMF) empowers Cetalkonium API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Cetalkonium JDMF during the approval evaluation for pharmaceutical products. At the time of Cetalkonium JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Cetalkonium suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cetalkonium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cetalkonium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cetalkonium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cetalkonium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cetalkonium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cetalkonium suppliers with NDC on PharmaCompass.
Cetalkonium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cetalkonium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cetalkonium GMP manufacturer or Cetalkonium GMP API supplier for your needs.
A Cetalkonium CoA (Certificate of Analysis) is a formal document that attests to Cetalkonium's compliance with Cetalkonium specifications and serves as a tool for batch-level quality control.
Cetalkonium CoA mostly includes findings from lab analyses of a specific batch. For each Cetalkonium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cetalkonium may be tested according to a variety of international standards, such as European Pharmacopoeia (Cetalkonium EP), Cetalkonium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cetalkonium USP).
LOOKING FOR A SUPPLIER?